CD8A and immune system disorder: Moreover, a previous study by our group has shown that YPF could improve the immune disorder in mice bearing with HCC by reducing the proportion of CD4+ CD25+ regulatory T cells, promoting the activation of CD8+ T cells, and increasing the proportion of memory CD8+ T cells.